NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
August 21, 2024 — InMed Pharmaceuticals announces confirmation of INM-901 oral formulation for Alzheimer's treatment, showcasing potential breakthrough in cannabinoid-based pharmaceutical drugs.
August 21, 2024 — Annovis Bio presents significant data and findings of its Phase 2/3 Alzheimer’s study of lead drug candidate buntanetap at the Alzheimer’s Association International Conference(R) 2024 (AAIC(R)) in Philadelphia, showcasing the drug's potential to improve the quality of life for early Alzheimer’s patients and its effectiveness in treating Parkinson’s and Alzheimer’s diseases.
August 21, 2024 — Discover how Glucotrack's Continuous Blood Glucose Monitor is revolutionizing diabetes management with its accurate and discreet monitoring solution. Learn how this technology has the potential to transform the lives of those with diabetes.
August 21, 2024 — Biotech companies are revolutionizing cancer treatment with innovative therapies. Learn about key players in the industry and the impact of their work on patients and investors.
August 21, 2024 — Skin & Shades Studio in San Joaquin County offers paramedical and camouflage tattooing services to help individuals restore physical integrity and emotional well-being after trauma or surgeries. Visit the studio in Stockton for scar revision, skin-color camouflage, and 3D areola tattooing.
August 20, 2024 — UNOS appoints Dr. Andrew S. Klein as Chief Medical Officer, bringing in expertise to lead the modernization of the nation’s transplant system and support UNOS' growth as a global leader in donation, transplant, and health.
August 20, 2024 — LogicMark (NASDAQ: LGMK) launches Aster safety app, expanding its product portfolio to support the safety needs of a growing population. The app broadens the company's offerings and addressable market, potentially reaching the global population.
August 20, 2024 — SaveRxCanada.to offers a cost-effective and safe solution for Americans seeking affordable prescription medications. By providing access to lower-priced medications from Canada, the platform is making a significant difference in the lives of countless individuals.
August 20, 2024 — SaveRxCanada.to offers a reliable and affordable alternative for U.S. consumers to access safe, effective, and significantly cheaper medications from licensed Canadian pharmacies. This can be a life-changing solution for patients with chronic conditions and eases the financial burden for individuals and families across the country.
August 19, 2024 — InMed Pharmaceuticals, a clinical stage company, is advancing innovative treatment for age-related macular degeneration (AMD) with its flagship product INM-089 showing great promise. The company is a global leader in the manufacturing, development, and commercialization of rare cannabinoids and proprietary cannabinoid analogs, offering new treatment alternatives for patients.
August 19, 2024 — Minerva Surgical appoints Darin Hammers as new President and CEO, demonstrating commitment to developing innovative gynecologic technologies for improved women's healthcare.
August 19, 2024 — ConV2X and Boston Blockchain Week collaborate for the 8th Annual Blockchain in Healthcare 2024 event, featuring top tier speakers and discussions on the latest challenges and innovations in blockchain technology for healthcare. Register now!
August 17, 2024 — Burhani Engineers successfully completes renewable energy project at major hospital in Malindi, Kenya, addressing critical power outage issues and significantly improving healthcare services.
August 17, 2024 — Discover the latest trends in the global sports market and the potential of new products like cotton kinesiology tape and sports tape. Major brands are making their mark in the industry, driven by the impact of the COVID-19 pandemic and increasing health awareness.
August 16, 2024 — Annovis Bio (ANVS) releases positive Phase 2/3 AD and Phase 3 PD study results, signaling potential breakthroughs in Alzheimer's and Parkinson's treatments.
August 16, 2024 — HeartBeam (BEAT) reports on Q2 2024 financial and operations results, highlighting progress toward clinical and regulatory milestones. The company's focus on personalized insights and advanced technology has the potential to revolutionize cardiac health management.
August 16, 2024 — CNS Pharmaceuticals releases Q2 2024 financial results and discusses clinical development progress of Berubicin and TPI 287 for the treatment of brain malignancies.
August 16, 2024 — Scinai Immunotherapeutics (NASDAQ: SCNI) publishes Q2 2024 financial results, showcasing progress in CDMO services, preclinical development, and upcoming clinical trials. Investors gain valuable insights into the company's performance and future plans.
August 15, 2024 — Consensus Health wins bronze Stevie® Award in 2024 International Business Awards® for its impressive strides in preserving clinical autonomy and positively impacting patient care.
August 15, 2024 — New study challenges traditional oral hygiene advice and highlights the critical role of rinsing in preventing dental implant loss. Learn about the effectiveness of molecular iodine oral care products.